Trial Profile
Combined chemotherapy with decetaxel and nedaplatin for advanced esophageal cancer, phaseI/II study.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 Feb 2013
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Nedaplatin (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 23 Aug 2011 New trial record